Victoria Watson

Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds

Laura Else, Victoria Watson, John Tjia et al. · Journal of Chromatography B · 2010 · 141 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

Kenneth Kintu, Thokozile R. Malaba, Jesca Nakibuka et al. · The Lancet HIV · 2020 · 125 citations · Full text

Medicine, Infectious Diseases, Obstetrics +16

Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy

Aylin Yilmaz, Chris Verhofstede, Antonio D’Avolio et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 69 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Malaria Chemoprevention in the Postdischarge Management of Severe Anemia

Titus K. Kwambai, Aggrey Dhabangi, Richard Idro et al. · New England Journal of Medicine · 2020 · 64 citations · Full text

Pharmacy, Child Health, Pediatrics +13

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients

Aylin Yilmaz, Victoria Watson, Laura Else et al. · AIDS · 2009 · 59 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17